Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-05

AUTHORS

Mitsunori Nishiyama, In-Sam Park, Tadahiro Yoshikawa, Yoshiho Hatai, Makoto Ando, Yukihiro Takahashi, Katsuhiko Mori, Yasuo Murakami

ABSTRACT

There have been few reports describing the use of carvedilol in children or patients with congenital heart disease. Therefore, its optimal regimen, efficacy, and safety in these patients have not been adequately investigated. Subjects were 27 patients with two functioning ventricles, for whom carvedilol was initiated (from December 2001 to December 2005) to treat heart failure. All patients had failed to respond to conventional cardiac medication. They consisted of 12 males and 15 females, aged 23 days to 47 years (median age: 2 years). Heart failure due to ischemia (myocardial infarction, intraoperative ischemic event) or due to myocardial disease (cardiomyopathy, myocarditis), and heart failure with atrial or ventricular tachyarrhythmia represented 70% of all cases. Carvedilol was initiated at a dose of 0.02-0.05 mg/kg/day, which was increased by 0.05-0.1 mg/kg/day after 2 days, 0.1 mg/kg/day after 5 days, and 0.05-0.1 mg/kg/day every month thereafter with a target dose of 0.8 mg/kg/day. This study retrospectively assessed the efficacy and adverse reactions based on changes of symptoms, cardiothoracic ratio (CTR), left ventricular ejection fraction (LVEF), and human atrial natriuretic peptide (hANP)/b-type natriuretic peptide (BNP) blood levels. The mean follow-up period was 10.2 months (range: 1-46 months). Twenty-six (96.3%) patients showed improvement in symptoms and were discharged from the hospital. However, the remaining one patient failed to respond and died. Significant cardiovascular adverse reaction was seen in none of the patients. The mean CTR decreased from 61.8% +/- 5.3% before treatment to 57.6% +/- 7.4% after treatment (P < 0.05, n = 25), and the mean LVEF improved from 41.4% +/- 23.1% to 61.1% +/- 10.1% (P < 0.05, n = 10), respectively. Mean hANP and BNP levels showed a decrease from 239.1 pg/ml to 118.3 pg/ml and a significant decrease from 437.9 pg/ml to 120.5 pg/ml, respectively (P < 0.05, n = 10). Improvements in these data were also demonstrated when analyzed individually among the pediatric group (aged younger than 18) and the congenital heart disease group. Initiation of carvedilol at a lower dose with more gradual dose escalation, compared with previously reported regimens, might have efficacy with low incidence of adverse effects in pediatric patients and patients with congenital heart disease. Carvedilol may be effective in treating heart failure in children due to ischemia, myocardial disease, and complicated by tachyarrhythmia. More... »

PAGES

187-192

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-008-1102-5

DOI

http://dx.doi.org/10.1007/s00380-008-1102-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041777117

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19466519


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carbazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carvedilol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Defects, Congenital", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant, Newborn", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propanolamines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishiyama", 
        "givenName": "Mitsunori", 
        "id": "sg:person.01036470454.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036470454.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "In-Sam", 
        "id": "sg:person.01256354276.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256354276.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshikawa", 
        "givenName": "Tadahiro", 
        "id": "sg:person.01071315666.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071315666.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hatai", 
        "givenName": "Yoshiho", 
        "id": "sg:person.01221032254.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221032254.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ando", 
        "givenName": "Makoto", 
        "id": "sg:person.0745625055.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745625055.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahashi", 
        "givenName": "Yukihiro", 
        "id": "sg:person.010476577562.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476577562.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mori", 
        "givenName": "Katsuhiko", 
        "id": "sg:person.01311251026.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311251026.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakakibara Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413411.2", 
          "name": [
            "Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murakami", 
        "givenName": "Yasuo", 
        "id": "sg:person.0663774233.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663774233.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.healun.2003.07.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002344321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)04560-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003099180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200105313442201", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004626599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2002.121265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005069506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199605233342101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007851848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2001.116768", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007992780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/heart.86.1.e4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011402658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199207233270403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012607218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-2498(02)00384-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021122141"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000066912.58385.de", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025238866"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-007-0993-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026128657", 
          "https://doi.org/10.1007/s00380-007-0993-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-007-0993-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026128657", 
          "https://doi.org/10.1007/s00380-007-0993-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mpd.2001.113045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026916053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/hrt.37.10.1022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027780628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(89)90019-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032047029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198706043162301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039054692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2002.124402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043148093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000018605.14470.dd", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046429221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-007-1016-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046771840", 
          "https://doi.org/10.1007/s00380-007-1016-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-007-1016-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046771840", 
          "https://doi.org/10.1007/s00380-007-1016-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(02)02570-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047574929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(02)02570-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047574929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.298.10.1171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050610802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075844130", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076617227", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-05", 
    "datePublishedReg": "2009-05-01", 
    "description": "There have been few reports describing the use of carvedilol in children or patients with congenital heart disease. Therefore, its optimal regimen, efficacy, and safety in these patients have not been adequately investigated. Subjects were 27 patients with two functioning ventricles, for whom carvedilol was initiated (from December 2001 to December 2005) to treat heart failure. All patients had failed to respond to conventional cardiac medication. They consisted of 12 males and 15 females, aged 23 days to 47 years (median age: 2 years). Heart failure due to ischemia (myocardial infarction, intraoperative ischemic event) or due to myocardial disease (cardiomyopathy, myocarditis), and heart failure with atrial or ventricular tachyarrhythmia represented 70% of all cases. Carvedilol was initiated at a dose of 0.02-0.05 mg/kg/day, which was increased by 0.05-0.1 mg/kg/day after 2 days, 0.1 mg/kg/day after 5 days, and 0.05-0.1 mg/kg/day every month thereafter with a target dose of 0.8 mg/kg/day. This study retrospectively assessed the efficacy and adverse reactions based on changes of symptoms, cardiothoracic ratio (CTR), left ventricular ejection fraction (LVEF), and human atrial natriuretic peptide (hANP)/b-type natriuretic peptide (BNP) blood levels. The mean follow-up period was 10.2 months (range: 1-46 months). Twenty-six (96.3%) patients showed improvement in symptoms and were discharged from the hospital. However, the remaining one patient failed to respond and died. Significant cardiovascular adverse reaction was seen in none of the patients. The mean CTR decreased from 61.8% +/- 5.3% before treatment to 57.6% +/- 7.4% after treatment (P < 0.05, n = 25), and the mean LVEF improved from 41.4% +/- 23.1% to 61.1% +/- 10.1% (P < 0.05, n = 10), respectively. Mean hANP and BNP levels showed a decrease from 239.1 pg/ml to 118.3 pg/ml and a significant decrease from 437.9 pg/ml to 120.5 pg/ml, respectively (P < 0.05, n = 10). Improvements in these data were also demonstrated when analyzed individually among the pediatric group (aged younger than 18) and the congenital heart disease group. Initiation of carvedilol at a lower dose with more gradual dose escalation, compared with previously reported regimens, might have efficacy with low incidence of adverse effects in pediatric patients and patients with congenital heart disease. Carvedilol may be effective in treating heart failure in children due to ischemia, myocardial disease, and complicated by tachyarrhythmia.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00380-008-1102-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "name": "Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease", 
    "pagination": "187-192", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c70240aa961b5f879c6ac502a7bf5b3def4f2f94d93677b2d81ca50fdb9ed132"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19466519"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8511258"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-008-1102-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041777117"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-008-1102-5", 
      "https://app.dimensions.ai/details/publication/pub.1041777117"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13078_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00380-008-1102-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1102-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1102-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1102-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1102-5'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      21 PREDICATES      68 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-008-1102-5 schema:about N03e85c7f7888478080e2f9edfccdc1eb
2 N0aa04d83685f4eb18002d57e66147427
3 N103f9ce5f0e64cc9b3ce4319740d1a0c
4 N10928b678d77473f8ae37621ee16e725
5 N2f57220043084f38aa9c4935f136841a
6 N59b05c812e7c46f4a43282c0e209dcaa
7 N64fe27f0793948da98f07187ee10de2f
8 N66a4a7bc74824155a548c06d0a547ab5
9 N78e3e58a2f26425494bbd47f8a39fd95
10 N7d01fa91bbe64a628195af9cbb77a3e6
11 N7da54fd342094615b51ed1bb89ee98d3
12 N82ed8bd53d1a4a69a616eaa32061e94c
13 N8739c97c6fd84ba0a97889d18eb39c4d
14 N8ca8468ba6ff4e5687910653603772f3
15 Na3e0a2bc972645e2ae8bff5c4511bfd0
16 Nabc85ed85f6c4753a65f12cec58146df
17 Nbdc30ea84833446997391bccb96c0800
18 anzsrc-for:11
19 anzsrc-for:1102
20 schema:author N9857e1d8285f4ef48686383c5b55c335
21 schema:citation sg:pub.10.1007/s00380-007-0993-x
22 sg:pub.10.1007/s00380-007-1016-7
23 https://app.dimensions.ai/details/publication/pub.1075844130
24 https://app.dimensions.ai/details/publication/pub.1076617227
25 https://doi.org/10.1001/jama.298.10.1171
26 https://doi.org/10.1016/0002-9149(89)90019-2
27 https://doi.org/10.1016/j.healun.2003.07.025
28 https://doi.org/10.1016/s0140-6736(00)04560-8
29 https://doi.org/10.1016/s0735-1097(02)02570-6
30 https://doi.org/10.1016/s1053-2498(02)00384-4
31 https://doi.org/10.1056/nejm198706043162301
32 https://doi.org/10.1056/nejm199207233270403
33 https://doi.org/10.1056/nejm199605233342101
34 https://doi.org/10.1056/nejm200105313442201
35 https://doi.org/10.1067/mhj.2001.116768
36 https://doi.org/10.1067/mhj.2002.121265
37 https://doi.org/10.1067/mhj.2002.124402
38 https://doi.org/10.1067/mpd.2001.113045
39 https://doi.org/10.1136/heart.86.1.e4
40 https://doi.org/10.1136/hrt.37.10.1022
41 https://doi.org/10.1161/01.cir.0000018605.14470.dd
42 https://doi.org/10.1161/01.cir.0000066912.58385.de
43 schema:datePublished 2009-05
44 schema:datePublishedReg 2009-05-01
45 schema:description There have been few reports describing the use of carvedilol in children or patients with congenital heart disease. Therefore, its optimal regimen, efficacy, and safety in these patients have not been adequately investigated. Subjects were 27 patients with two functioning ventricles, for whom carvedilol was initiated (from December 2001 to December 2005) to treat heart failure. All patients had failed to respond to conventional cardiac medication. They consisted of 12 males and 15 females, aged 23 days to 47 years (median age: 2 years). Heart failure due to ischemia (myocardial infarction, intraoperative ischemic event) or due to myocardial disease (cardiomyopathy, myocarditis), and heart failure with atrial or ventricular tachyarrhythmia represented 70% of all cases. Carvedilol was initiated at a dose of 0.02-0.05 mg/kg/day, which was increased by 0.05-0.1 mg/kg/day after 2 days, 0.1 mg/kg/day after 5 days, and 0.05-0.1 mg/kg/day every month thereafter with a target dose of 0.8 mg/kg/day. This study retrospectively assessed the efficacy and adverse reactions based on changes of symptoms, cardiothoracic ratio (CTR), left ventricular ejection fraction (LVEF), and human atrial natriuretic peptide (hANP)/b-type natriuretic peptide (BNP) blood levels. The mean follow-up period was 10.2 months (range: 1-46 months). Twenty-six (96.3%) patients showed improvement in symptoms and were discharged from the hospital. However, the remaining one patient failed to respond and died. Significant cardiovascular adverse reaction was seen in none of the patients. The mean CTR decreased from 61.8% +/- 5.3% before treatment to 57.6% +/- 7.4% after treatment (P < 0.05, n = 25), and the mean LVEF improved from 41.4% +/- 23.1% to 61.1% +/- 10.1% (P < 0.05, n = 10), respectively. Mean hANP and BNP levels showed a decrease from 239.1 pg/ml to 118.3 pg/ml and a significant decrease from 437.9 pg/ml to 120.5 pg/ml, respectively (P < 0.05, n = 10). Improvements in these data were also demonstrated when analyzed individually among the pediatric group (aged younger than 18) and the congenital heart disease group. Initiation of carvedilol at a lower dose with more gradual dose escalation, compared with previously reported regimens, might have efficacy with low incidence of adverse effects in pediatric patients and patients with congenital heart disease. Carvedilol may be effective in treating heart failure in children due to ischemia, myocardial disease, and complicated by tachyarrhythmia.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf N6e15de0779bd4c3b83831f9e67665615
50 Ne3358e2675c647d690b67a54061b4fb7
51 sg:journal.1095887
52 schema:name Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease
53 schema:pagination 187-192
54 schema:productId N64b2d1b5c4be46b7a78f3c7048443f9b
55 Nbf63eb95482943998aefb070243fa7bc
56 Nc623452f2cd44f42ae82fef6946a18c8
57 Ne70565189247476194b0150e45fdf8d1
58 Nfc26474a56a14bf281e72f2806274563
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041777117
60 https://doi.org/10.1007/s00380-008-1102-5
61 schema:sdDatePublished 2019-04-11T14:28
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher Nf3fad5186944434b9a4d37af9d5eef82
64 schema:url http://link.springer.com/10.1007%2Fs00380-008-1102-5
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N03e85c7f7888478080e2f9edfccdc1eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Infant, Newborn
70 rdf:type schema:DefinedTerm
71 N0aa04d83685f4eb18002d57e66147427 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Humans
73 rdf:type schema:DefinedTerm
74 N103f9ce5f0e64cc9b3ce4319740d1a0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Heart Failure
76 rdf:type schema:DefinedTerm
77 N10928b678d77473f8ae37621ee16e725 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Male
79 rdf:type schema:DefinedTerm
80 N2f57220043084f38aa9c4935f136841a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Female
82 rdf:type schema:DefinedTerm
83 N30a1f9a117b64879991df4866eece567 rdf:first sg:person.01071315666.52
84 rdf:rest N4b35f68059874dd296a08b099c38b485
85 N4168c3dfa2ed47a68f5375577de0b64c rdf:first sg:person.0663774233.49
86 rdf:rest rdf:nil
87 N4b35f68059874dd296a08b099c38b485 rdf:first sg:person.01221032254.24
88 rdf:rest Na7b18f19ca6d485c8145f45b9fe1ec16
89 N59b05c812e7c46f4a43282c0e209dcaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Propanolamines
91 rdf:type schema:DefinedTerm
92 N64b2d1b5c4be46b7a78f3c7048443f9b schema:name pubmed_id
93 schema:value 19466519
94 rdf:type schema:PropertyValue
95 N64fe27f0793948da98f07187ee10de2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adolescent
97 rdf:type schema:DefinedTerm
98 N66a4a7bc74824155a548c06d0a547ab5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Carbazoles
100 rdf:type schema:DefinedTerm
101 N6e15de0779bd4c3b83831f9e67665615 schema:issueNumber 3
102 rdf:type schema:PublicationIssue
103 N701c368449f948d581bef14daa30e6e2 rdf:first sg:person.010476577562.41
104 rdf:rest Nb273a0a51b0e43ebb3fee9006c927e99
105 N78e3e58a2f26425494bbd47f8a39fd95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Child, Preschool
107 rdf:type schema:DefinedTerm
108 N7d01fa91bbe64a628195af9cbb77a3e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Adrenergic beta-Antagonists
110 rdf:type schema:DefinedTerm
111 N7da54fd342094615b51ed1bb89ee98d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Infant
113 rdf:type schema:DefinedTerm
114 N82ed8bd53d1a4a69a616eaa32061e94c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Carvedilol
116 rdf:type schema:DefinedTerm
117 N8739c97c6fd84ba0a97889d18eb39c4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Heart Defects, Congenital
119 rdf:type schema:DefinedTerm
120 N8ca8468ba6ff4e5687910653603772f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Child
122 rdf:type schema:DefinedTerm
123 N9857e1d8285f4ef48686383c5b55c335 rdf:first sg:person.01036470454.30
124 rdf:rest Nf492747a96e340f598e3e9a33d89fb2c
125 Na3e0a2bc972645e2ae8bff5c4511bfd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Treatment Outcome
127 rdf:type schema:DefinedTerm
128 Na7b18f19ca6d485c8145f45b9fe1ec16 rdf:first sg:person.0745625055.78
129 rdf:rest N701c368449f948d581bef14daa30e6e2
130 Nabc85ed85f6c4753a65f12cec58146df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Middle Aged
132 rdf:type schema:DefinedTerm
133 Nb273a0a51b0e43ebb3fee9006c927e99 rdf:first sg:person.01311251026.94
134 rdf:rest N4168c3dfa2ed47a68f5375577de0b64c
135 Nbdc30ea84833446997391bccb96c0800 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Adult
137 rdf:type schema:DefinedTerm
138 Nbf63eb95482943998aefb070243fa7bc schema:name readcube_id
139 schema:value c70240aa961b5f879c6ac502a7bf5b3def4f2f94d93677b2d81ca50fdb9ed132
140 rdf:type schema:PropertyValue
141 Nc623452f2cd44f42ae82fef6946a18c8 schema:name doi
142 schema:value 10.1007/s00380-008-1102-5
143 rdf:type schema:PropertyValue
144 Ne3358e2675c647d690b67a54061b4fb7 schema:volumeNumber 24
145 rdf:type schema:PublicationVolume
146 Ne70565189247476194b0150e45fdf8d1 schema:name nlm_unique_id
147 schema:value 8511258
148 rdf:type schema:PropertyValue
149 Nf3fad5186944434b9a4d37af9d5eef82 schema:name Springer Nature - SN SciGraph project
150 rdf:type schema:Organization
151 Nf492747a96e340f598e3e9a33d89fb2c rdf:first sg:person.01256354276.15
152 rdf:rest N30a1f9a117b64879991df4866eece567
153 Nfc26474a56a14bf281e72f2806274563 schema:name dimensions_id
154 schema:value pub.1041777117
155 rdf:type schema:PropertyValue
156 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
157 schema:name Medical and Health Sciences
158 rdf:type schema:DefinedTerm
159 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
160 schema:name Cardiorespiratory Medicine and Haematology
161 rdf:type schema:DefinedTerm
162 sg:journal.1095887 schema:issn 0910-8327
163 1615-2573
164 schema:name Heart and Vessels
165 rdf:type schema:Periodical
166 sg:person.01036470454.30 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
167 schema:familyName Nishiyama
168 schema:givenName Mitsunori
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036470454.30
170 rdf:type schema:Person
171 sg:person.010476577562.41 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
172 schema:familyName Takahashi
173 schema:givenName Yukihiro
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476577562.41
175 rdf:type schema:Person
176 sg:person.01071315666.52 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
177 schema:familyName Yoshikawa
178 schema:givenName Tadahiro
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071315666.52
180 rdf:type schema:Person
181 sg:person.01221032254.24 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
182 schema:familyName Hatai
183 schema:givenName Yoshiho
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221032254.24
185 rdf:type schema:Person
186 sg:person.01256354276.15 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
187 schema:familyName Park
188 schema:givenName In-Sam
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256354276.15
190 rdf:type schema:Person
191 sg:person.01311251026.94 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
192 schema:familyName Mori
193 schema:givenName Katsuhiko
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311251026.94
195 rdf:type schema:Person
196 sg:person.0663774233.49 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
197 schema:familyName Murakami
198 schema:givenName Yasuo
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663774233.49
200 rdf:type schema:Person
201 sg:person.0745625055.78 schema:affiliation https://www.grid.ac/institutes/grid.413411.2
202 schema:familyName Ando
203 schema:givenName Makoto
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745625055.78
205 rdf:type schema:Person
206 sg:pub.10.1007/s00380-007-0993-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026128657
207 https://doi.org/10.1007/s00380-007-0993-x
208 rdf:type schema:CreativeWork
209 sg:pub.10.1007/s00380-007-1016-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046771840
210 https://doi.org/10.1007/s00380-007-1016-7
211 rdf:type schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1075844130 schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1076617227 schema:CreativeWork
214 https://doi.org/10.1001/jama.298.10.1171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050610802
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/0002-9149(89)90019-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032047029
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/j.healun.2003.07.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002344321
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/s0140-6736(00)04560-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003099180
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/s0735-1097(02)02570-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047574929
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/s1053-2498(02)00384-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021122141
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1056/nejm198706043162301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039054692
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1056/nejm199207233270403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012607218
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1056/nejm199605233342101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007851848
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1056/nejm200105313442201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004626599
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1067/mhj.2001.116768 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007992780
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1067/mhj.2002.121265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005069506
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1067/mhj.2002.124402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043148093
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1067/mpd.2001.113045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026916053
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1136/heart.86.1.e4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011402658
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1136/hrt.37.10.1022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027780628
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1161/01.cir.0000018605.14470.dd schema:sameAs https://app.dimensions.ai/details/publication/pub.1046429221
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1161/01.cir.0000066912.58385.de schema:sameAs https://app.dimensions.ai/details/publication/pub.1025238866
249 rdf:type schema:CreativeWork
250 https://www.grid.ac/institutes/grid.413411.2 schema:alternateName Sakakibara Memorial Hospital
251 schema:name Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho Fuchu, 183-0003, Tokyo, Japan
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...